Nyring, Marc Randall Kristensen http://orcid.org/0000-0001-5964-5602
Olsen, Bo S.
Yilmaz, Müjgan
Petersen, Michael M.
Flivik, Gunnar
Rasmussen, Jeppe V.
Funding for this research was provided by:
Zimmer Biomet (MS50976)
Gentofte Hospital
Article History
Received: 15 March 2020
Accepted: 22 September 2020
First Online: 7 October 2020
Ethics approval and consent to participate
: The trial will be conducted according to the ethics outlined in the Helsinki Declaration [CitationRef removed]. All patients will receive oral and written information before they are asked to sign an informed consent form. The participating patient can withdraw their consent at any time.The Danish National Committee on Health Research Ethics has approved this study protocol (approval reference number <i>H-20017412 - H-19053566</i>), including the informed consent form and patient information sheets.The extra radiation dosage due to additional radiographic examinations in this study is 0.10 mSv. The background radiation in Denmark is 3 mSv each year. Therefore, the extra radiation dosage of 0.10 mSv from this study corresponds to the background radiation during approximately 12 days.
: Not applicable.
: One of the authors (BO) has previously given a paid lecture to the manufacturer, Zimmer Biomet, and one of the authors (MP) has previously received funding (institutional research support) for other investigator-initiated and industry-initiated research studies from Zimmer Biomet. However, Zimmer Biomet has not had any role in the design of the study and will not be involved in execution of the study or analysis or interpretation of study results and have no influence on the decision to submit the results for publication.